UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor–modulating agent

Journal of the American Academy of Dermatology, 2021-04, Vol.84 (4), p.1059-1067

2021

Volltextzugriff (PDF)

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

Journal of the American Academy of Dermatology, 2016-09, Vol.75 (3), p.494-503.e6

2016

Volltextzugriff (PDF)

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

The New England journal of medicine, 2023-03, Vol.388 (12), p.1080-1091

2023

Volltextzugriff (PDF)

Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials

JAMA dermatology (Chicago, Ill.), 2022-04, Vol.158 (4), p.404

2022

Volltextzugriff (PDF)

Guidelines of care for the management of acne vulgaris

Journal of the American Academy of Dermatology, 2016-05, Vol.74 (5), p.945-973.e33

2016

Volltextzugriff (PDF)

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis

The New England journal of medicine, 2021-12, Vol.385 (24), p.2219-2229

2021

Volltextzugriff (PDF)

A phase 2b, randomized clinical trial of tapinarof cream for the treatment of plaque psoriasis: Secondary efficacy and patient-reported outcomes

Journal of the American Academy of Dermatology, 2021-03, Vol.84 (3), p.624-631

2021

Volltextzugriff (PDF)

Trial of Roflumilast Cream for Chronic Plaque Psoriasis

The New England journal of medicine, 2020-07, Vol.383 (3), p.229-239

2020

Volltextzugriff (PDF)

OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study

Journal of the American Academy of Dermatology, 2016-08, Vol.75 (2), p.297-305

2016

Volltextzugriff (PDF)

Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis

Journal of the American Academy of Dermatology, 2017-10, Vol.77 (4), p.641-649.e5

2017

Volltextzugriff (PDF)

The importance of early diagnosis and treatment of actinic keratosis

Journal of the American Academy of Dermatology, 2013-01, Vol.68 (1), p.S20-S27

2013

Volltextzugriff (PDF)

Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology

The Journal of dermatological treatment, 2021-05, Vol.32 (4), p.391-398

2021

Volltextzugriff (PDF)

Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups

American journal of clinical dermatology, 2019-10, Vol.20 (5), p.711-723

2019

Volltextzugriff (PDF)

The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review

Acta dermato-venereologica, 2021-10, Vol.101 (10), p.adv00584-adv00584

2021

Volltextzugriff (PDF)

Importance of treating acne sequelae in skin of color: 6‐month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne‐induced post‐inflammatory hyperpigmentation

International journal of dermatology, 2024-06, Vol.63 (6), p.806-815

2024

Volltextzugriff (PDF)

Guidelines of care for the management of acne vulgaris

Journal of the American Academy of Dermatology, 2024-05, Vol.90 (5), p.1006.e1-1006.e30

2024

Volltextzugriff (PDF)

Topical clindamycin for acne vulgaris: analysis of gastrointestinal events

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2325603-2325603

2024

Volltextzugriff (PDF)

Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis

Dermatitis, 2024-02, Vol.35 (1), p.84-91

2024

Volltextzugriff (PDF)

Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse)

British journal of dermatology (1951), 2023-10, Vol.189 (5), p.540-552

2023

Volltextzugriff (PDF)

Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials

The Journal of dermatological treatment, 2023-12, Vol.34 (1), p.2220446-2220446

2023

Volltextzugriff (PDF)

Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis

The Journal of dermatological treatment, 2022-05, Vol.33 (4), p.2068-2074

2022

Volltextzugriff (PDF)

Current Concepts in Acne Pathogenesis: Pathways to Inflammation

Seminars in cutaneous medicine and surgery, 2018-06, Vol.37 (3S), p.S60-S62

2018

Volltextzugriff (PDF)

Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies

Dermatology and therapy, 2023-09, Vol.13 (9), p.2031-2044

2023

Volltextzugriff (PDF)

Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials

JAMA dermatology (Chicago, Ill.), 2020-06, Vol.156 (6), p.621

2020

Volltextzugriff (PDF)

1 – 25 von 455

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(432)
Mit Volltextzugriff
(314)

Publikationsform

Artikel
(454)
Buchkapitel
(1)

Sprache

Englisch
(455)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(186)
Life Sciences & Biomedicine
(185)
Dermatology
(183)
Humans
(134)
Treatment Outcome
(72)
Female
(64)
Male
(63)
Adult
(60)
Double-Blind Method
(58)
Severity Of Illness Index
(58)
Adolescent
(50)
Psoriasis - Drug Therapy
(42)
Dermatologic Agents - Therapeutic Use
(41)
Acne Vulgaris - Drug Therapy
(38)
Administration, Cutaneous
(38)
Child
(37)
Dermatologic Agents - Administration & Dosage
(37)
Middle Aged
(33)
Young Adult
(32)
Drug Combinations
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(24)
... seit 90 Tagen
(43)

Menü

Weitere Dienste

Einstellungen

Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor–modulating agent

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials

Guidelines of care for the management of acne vulgaris

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis

A phase 2b, randomized clinical trial of tapinarof cream for the treatment of plaque psoriasis: Secondary efficacy and patient-reported outcomes

Trial of Roflumilast Cream for Chronic Plaque Psoriasis

OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study

Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis

The importance of early diagnosis and treatment of actinic keratosis

Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology

Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups

Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials

The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review

Importance of treating acne sequelae in skin of color: 6‐month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne‐induced post‐inflammatory hyperpigmentation

Guidelines of care for the management of acne vulgaris

Topical clindamycin for acne vulgaris: analysis of gastrointestinal events

Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis

Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse)

Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials

Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis

Current Concepts in Acne Pathogenesis: Pathways to Inflammation

Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies

Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials

Suchergebnisse filtern